Showing results (241-250 of 258) with videos related to
Sort By:
Pageof 26
Circulation. Cardiovascular Interventions|March 16, 2019
Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by StrokeWieneke Vlastra, Pilar Jimenez-Quevedo, Didier Tchétché, et al.The American Journal of Cardiology|June 1, 2014
Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study)Fausto Biancari, Tomas Gudbjartsson, Jouni Heikkinen, et al.Journal of the American Heart Association|March 18, 2026
Simple Index for Identifying Patients at Increased Risk of Suboptimal Forward-Flow Hemodynamics After Transcatheter Aortic Valve ReplacementPier Pasquale Leone, Damiano Regazzoli, Matteo Sturla, et al.Journal of the American College of Cardiology|October 8, 2025
Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position StatementSimone Fezzi, Patrick W Serruys, Bernardo Cortese, et al.Journal of the American College of Cardiology|January 19, 2019
Mid-Term Valve-Related Outcomes After Transcatheter Tricuspid Valve-in-Valve or Valve-in-Ring ReplacementDoff B McElhinney, Jamil A Aboulhosn, Danny Dvir, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.European Heart Journal|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 20, 2020
ImpaCt of an Optimal Implantation Strategy on Absorb Long-Term Outcomes: The CIAO RegistryClaudio Rapetto, Massimo Leoncini, Enrico Cerrato, et al.Cardiovascular Diabetology|May 21, 2025
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI)Pasquale Paolisso, Marta Belmonte, Emanuele Gallinoro, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 20, 2025
Secondary access and routine protection wire for transfemoral transcatheter aortic valve replacement: the SURF-TAVR registryOttavia Cozzi, Prem Ratan, Giulia Costa, et al.Pageof 26